Uribur 40 Number 23 (Paramesh Banerji Life Sciences LLC)
Welcome to the PulseAid listing for the Uribur 40 Number 23 drug offered from Paramesh Banerji Life Sciences LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Paramesh Banerji Life Sciences LLC |
| NON-PROPRIETARY NAME: | Lycopodium, Ignatia amara |
| SUBSTANCE NAME: | LYCOPODIUM CLAVATUM SPORE; STRYCHNOS IGNATII SEED |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | PELLET |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2015-01-13 |
| END MARKETING DATE: | 0000-00-00 |
Uribur 40 Number 23 HUMAN OTC DRUG Details:
| Item Description | Uribur 40 Number 23 from Paramesh Banerji Life Sciences LLC |
| LABELER NAME: | Paramesh Banerji Life Sciences LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 200; 30([hp_C]/1; [hp_C]/1) |
| START MARKETING DATE: | 2015-01-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69152-0023_1023b43f-1b06-0eae-e054-00144ff88e88 |
| PRODUCT NDC: | 69152-0023 |
| APPLICATION NUMBER: | |
Other LYCOPODIUM CLAVATUM SPORE; STRYCHNOS IGNATII SEED Pharmaceutical Manufacturers / Labelers:
